Compass Pathways Board Chair And Co-Founder George Goldsmith And Co-Founder Ekaterina Malievskaia Step Down From Board Of Directors, Effective March 29, 2024
Portfolio Pulse from Benzinga Newsdesk
Compass Pathways co-founders George Goldsmith and Ekaterina Malievskaia have resigned from the board, effective March 29, 2024. David Norton will serve as interim chair while the company searches for a permanent replacement. The company highlights its progress in developing psilocybin treatment for treatment-resistant depression and its achievements under the leadership of Goldsmith and Malievskaia, including FDA Breakthrough Therapy Designation and successful financing rounds.
March 28, 2024 | 12:09 pm
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
Compass Pathways announces the resignation of its co-founders from the board, with David Norton stepping in as interim chair. The company continues to progress in its development of psilocybin treatment for depression.
The resignation of the co-founders might bring uncertainty in the short term, but the appointment of an experienced interim chair and the company's ongoing progress in treatment development could stabilize the situation. The company's achievements and strategic focus on mental health innovation remain strong, suggesting a neutral to slightly positive outlook.
CONFIDENCE 90
IMPORTANCE 75
RELEVANCE 100